VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.4230
-0.0081 (-1.88%)
Nov 6, 2025, 11:07 AM EST - Market open
VolitionRx Employees
VolitionRx had 85 employees as of December 31, 2024. The number of employees decreased by 25 or -22.73% compared to the previous year.
Employees
85
Change (1Y)
-25
Growth (1Y)
-22.73%
Revenue / Employee
$15,521
Profits / Employee
-$274,385
Market Cap
50.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 85 | -25 | -22.73% |
| Dec 31, 2023 | 110 | 6 | 5.77% |
| Dec 31, 2022 | 104 | 21 | 25.30% |
| Dec 31, 2021 | 83 | 18 | 27.69% |
| Dec 31, 2020 | 65 | 15 | 30.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VNRX News
- 20 days ago - Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs - PRNewsWire
- 27 days ago - VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants - PRNewsWire
- 27 days ago - VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants - PRNewsWire
- 4 weeks ago - VolitionRx Limited - Special Call - Seeking Alpha
- 5 weeks ago - Volition Sponsors Upcoming GenomeWeb Webinar - PRNewsWire
- 5 weeks ago - Volition Signs Co-Marketing and Services Agreement with Hologic - PRNewsWire
- 2 months ago - Volition Signs First Human Out Licensing Deal - PRNewsWire
- 2 months ago - VolitionRx Limited (VNRX) Q2 2025 Earnings Call Transcript - Seeking Alpha